ASX Announcements

Establishment of Nyrada Inc.
Positive Clinical Outcomes for NOX66 at ESMO Conference
Change in substantial holding
Change in substantial holding
Placement completed App 3B, s708 Notice, LR7.1A4(b) Notice
NOX CEO Interview explains recent Brain Cancer Announcement
Appendix 4E and Audited Financial Statements
Corporate Governance Statement - Appendix 4G
Corporate Governance Statement
Important Brain Cancer Findings for NOX66 Program